accountmedicines are invented and also in how they are sold. In November, when the first generic versions of Pfizer���s...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
PFIZER
Pfizer, Inc. is the world’s largest pharmaceutical company in the world, by sales. The New York-based company produces the No. 1-selling drug, along with other widely used prescription drugs as Lipitor, Lyriuca, Diflucan, Celebrex and Viagra. This topic covers the latest news on Pfizer.
Pfizer is part of Business Exchange, suggested by
Maki Yamasaki.
This topic contains
1,240 news
and
381 blog
items.
Read updated news, blogs, and resources about Pfizer. Find user-submitted articles and reactions on Pfizer from
like-minded professionals.
News
Please add new articles to this topic
drug had serious side effects, the potential benefits for patients suffering from the rare cancer outweighed the risks.
production in the first quarter. Shares of the company were rising 0.9% to $72.75. Drug companies Pfizer(PFE) and...
Facing generic competition for its little blue pill, Pfizer recently started selling a chewable form of Viagra in...
It wasn't perfect for Pfizer (NYSE: PFE Yesterday a Food and Drug Administration advisory committee voted 8-2...
two drugs for rare form of pancreatic cancer The panel finds that the benefits of Novartis' Afinitor and Pfizer's...
trade higher) or offer some thoughts on health care. Big Pharma, like Big Oil, is mostly loer today. Pfizer, Merck,...
A Food and Drug Administration panel has voted to recommend for approval drugs from Pfizer and Novartis.
FDA's expert advisors gave two thumbs up yesterday.
UFEs). Topping the list, according to Ciesielski's estimates, is GE, with $94 billion in UFEs, followed by Pfizer (PFE,...
A Food and Drug Administration panel has voted to recommend for approval drugs from Pfizer (PFE) [...]
to other subsectors. In the big pharmaceuticals, there is only one name that stands out, and that is Pfizer .
International following a report in the Wall Street Journal that the French company made a $30 billion approach.
FDA Panel Votes: Kidney-cancer drugs made by Pfizer and Novartis have received a thumbs-up from an FDA advisory panel,...
The panel finds that the benefits of Novartis' Afinitor and Pfizer's Sutent outweigh their side effects in treating...
12, 2011 (MARKETWIRE via COMTEX) -- NC MedAssist, the statewide free pharmacy program, today announced a partnership...
EDT SILVER SPRING, Maryland (Reuters) - A U.S. advisory panel backed cancer drugs by Pfizer Inc and Novartis AG for...
at the 63rd Annual Meeting of the American Academy of Neurology HONOLULU, Apr 12, 2011 (BUSINESS WIRE) -- Pfizer Inc.
profit excluding some costs of 9 cents a share, matching the average analyst estimate in a Bloomberg survey. Pfizer Inc.
Food and Drug Administration said today in a 10-0 vote in White Oak, Maryland. The panel later backed Pfizer Inc.
April 12 (Bloomberg) -- Pfizer Inc. won a U.S. panel���s backing to expand marketing of a cancer drug for patients with...
6:51pm EDT * Panel backs Pfizer, Novartis drugs for pancreatic cancer * Panelists recommend further studies for...
for advanced kidney cancer and gastrointestinal stromal tumors and brings in more than $1 billion in annual sales.
(BUSINESS WIRE) -- Pfizer Inc. announced today that the U.S. FDA Oncologic Drugs Advisory Committee (ODAC) voted 8-2...
Pfizer Inc. announced today that the U.S. FDA Oncologic Drugs Advisory Committee (ODAC) voted 8-2 that SUTENT��...
Top Sources: Pfizer
- blogs.barrons.com
- BusinessWeek
- knowledge.wharton.upenn.edu
- online.wsj.com
- MarketWatch
- Motley Fool
- SeekingAlpha.com
- New York Times
- TheStreet.com
- Forbes.com
